Article Information
History
- March 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Murray Dryden1,*,
- Caroline Mudara1,
- Caroline Vika1,
- Lucille Blumberg1,
- Natalie Mayet1,
- Cheryl Cohen2,3,
- Stefano Tempia2,3,
- Arifa Parker4,
- Jeremy Nel5,
- Rubeshan Perumal6,7,
- Michelle J. Groome1,8,
- Francesca Conradie9,
- Norbert Ndjeka10,
- Louise Sigfrid11,
- Laura Merson12 and
- Waasila Jassat1
- 1National Institute for Communicable Disease, Division of the National Health Laboratory Services, Johannesburg, South Africa
- 2School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 3Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Disease, Johannesburg, South Africa
- 4Divisions of General Medicine and Infectious Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town
- 5Division of Infectious Diseases, Department of Medicine, University of the Witwatersrand, Johannesburg
- 6Centre for Lung Infection and Immunity, Pulmonology, Division of Infectious Diseases, Department of Medicine, University of Cape Town, Cape Town
- 7South African Medical Research Council-CAPRISA HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban
- 8School of Pathology, Faculty of Health Sciences, University of Witwatersrand
- 9Clinical HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg
- 10Drug-Resistant TB, TB & HIV Directorate, National Department of Health, Pretoria, South Africa and University of KwaZulu-Natal, Durban
- 11International Severe Actue Respiratory and emerging Infections Consortium (ISARIC) Global Support Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 12International Severe Actue Respiratory and emerging Infections Consortium (ISARIC), Pandemic Sciences Centre, University of Oxford, UK
- ↵*Corresponding author:
Dr Murray Dryden, Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, 1 Modderfontein Road Sandringham, Email: murrayd{at}nicd.ac.za; murray.dryden{at}live.co.za
Posted March 08, 2022.
Post COVID-19 Condition in South Africa: 3-month follow-up after hospitalisation with SARS-CoV-2
